Modern biologics for rabies prophylaxis and the elimination of human cases mediated by dogs

References

• Tarantola A. Four thousand years of concepts relating to rabies in animals and humans, its prevention and its cure. Trop Med Infect Dis. 2017;2(2):21.
   Google Scholar
• Fooks AR, Cliquet F, Finke S, et al. Rabies. Nat Rev Dis Primers. 2017;3:17091.
   PubMed Web of Science ®Google Scholar
• Hampson K, Coudeville L, Lembo T, et al. Estimating the global burden of endemic canine rabies. PLoS Negl Trop Dis. 2015;9:e0003709.
   PubMed Web of Science ®Google Scholar
• Abela-Ridder B, Knopf L, Martin S, et al. the beginning of the end of rabies? Lancet Glob Health. 2016;4:e780–e781.
   PubMed Web of Science ®Google Scholar
• Amarasinghe GK, Ayllón MA, Bào Y, et al. Taxonomy of the order Mononegavirales: update 2019. Arch Virol. 2019;164:1967–1980.
   PubMed Web of Science ®Google Scholar
• Nikolic J, Lagaudrière-Gesbert C, Scrima N, et al. Structure and function of negri bodies. Adv Exp Med Biol. 2019;1215:111–127.
   PubMed Web of Science ®Google Scholar
• Ito N, Moseley GW, Sugiyama M. The importance of immune evasion in the pathogenesis of rabies virus. J Vet Med Sci. 2016;78:1089–1098.
   PubMed Web of Science ®Google Scholar
• Sonthonnax F, Besson B, Bonnaud E, et al. Lyssavirus matrix protein cooperates with phosphoprotein to modulate the Jak-Stat pathway. Sci Rep. 2019;9:12171.
   PubMed Web of Science ®Google Scholar
• Belot L, Albertini A, Gaudin Y. Structural and cellular biology of rhabdovirus entry. Adv Virus Res. 2019;104:147–183.
   PubMed Web of Science ®Google Scholar
• Fernando BG, Yersin CT, José CB, et al. Predicted 3D model of the rabies virus glycoprotein trimer. Biomed Res Int. 2016;2016:1674580.
   PubMed Web of Science ®Google Scholar
• Ogino T, Green TJ. Transcriptional control and mRNA capping by the GDP polyribonucleotidyltransferase domain of the rabies virus large protein. Viruses. 2019;11(6). 10.3390/v11060504
   Web of Science ®Google Scholar
• Rupprecht CE, Kuzmin IV, Yale G, et al. Priorities in applied research to ensure programmatic success in the global elimination of canine rabies. Vaccine. 2019;37(Suppl 1):A77–A84.
   PubMed Web of Science ®Google Scholar
• Walker PJ, Blasdell KR, Calisher CH, et al. ICTV virus taxonomy profile: rhabdoviridae. J Gen Virol. 2018;99:447–448.
   PubMed Web of Science ®Google Scholar
• Jackson AC. Rabies: a medical perspective. Rev Sci Tech. 2018;37:569–580.
   PubMed Web of Science ®Google Scholar
• Davis BM, Rall GF, Schnell MJ. Everything you always wanted to know about rabies virus (But were afraid to ask). Annu Rev Virol. 2015;2(1):451–471.
   PubMed Web of Science ®Google Scholar
• Ugolini G, Hemachudha T. Rabies: changing prophylaxis and new insights in pathophysiology. Curr Opin Infect Dis. 2018;31:93–101.
   PubMed Web of Science ®Google Scholar
• Guo C, Li Y, Huai Y, et al. Exposure history, post-exposure prophylaxis use, and clinical characteristics of human rabies cases in China, 2006-2012. Sci Rep. 2018 Nov 21;8(1):17188.
   PubMed Web of Science ®Google Scholar
• Boland TA, McGuone D, Jindal J, et al. Phylogenetic and epidemiologic evidence of multiyear incubation in human rabies. Ann Neurol. 2014;75:155–160.
   PubMed Web of Science ®Google Scholar
• Mani RS, Damodar T, Domala SD, et al. Case reports: survival from rabies: case series from India. Am J Trop Med Hyg. 2019;100:165–169.
   PubMed Web of Science ®Google Scholar
• Rupprecht CE, Bannazadeh Baghi H, Del Rio Vilas VJ, et al. Historical, current and expected future occurrence of rabies in enzootic regions. Rev Sci Tech. 2018;37(2):729–739.
   PubMed Web of Science ®Google Scholar
• Freire de Carvalho M, Vigilato MAN,Pompei JA. Rabies in the Americas: 1998-2014. PLoS Negl Trop Dis. 12(3): e0006271. 2018.
   PubMed Web of Science ®Google Scholar
• Sinclair JR, Wallace RM, Gruszynski K, et al. Rabies in a dog imported from Egypt with a falsified rabies vaccination certificate–Virginia, 2015. Morb Mortal Wkly Rep. 2015;64:1359–1362.
   PubMed Web of Science ®Google Scholar
• Gilbert AT. Rabies virus vectors and reservoir species. Rev Sci Tech. 2018;37:371–384.
   PubMed Web of Science ®Google Scholar
• Baby J, Mani RS, Abraham SS, et al. Natural rabies infection in a domestic fowl (Gallus domesticus): a report from India. PLoS Negl Trop Dis. 2015;9:e0003942.
   PubMed Web of Science ®Google Scholar
• Ma X, Monroe BP, Cleaton JM, et al. Rabies surveillance in the United States during 2018. J Am Vet Med Assoc. 2020;256:195–208.
   PubMed Web of Science ®Google Scholar
• Markotter W, Coertse J. Bat lyssaviruses. Rev Sci Tech. 2018;37:385–400.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick JL, Dyer JL, Blanton JD, et al. Rabies in rodents and lagomorphs in the United States, 1995-2010. J Am Vet Med Assoc. 2014;245:333–337.
   PubMed Web of Science ®Google Scholar
• Soler-Rangel S, Jiménez-Restrepo N, Nariño D, et al. Rabies encephalitis and extra-neural manifestations in a patient bitten by a domestic cat. Rev Inst Med Trop Sao Paulo. 2020 Jan 17;62:e1.
   PubMed Web of Science ®Google Scholar
• Mbilo C, Lechenne M, Mauti S, et al. Rabies in dogs, livestock and wildlife: a veterinary perspective. Rev Sci Tech. 2018;37:331–340.
   PubMed Web of Science ®Google Scholar
• Kuzmin IV, Shi M, Orciari LA, et al. Molecular inferences suggest multiple host shifts of rabies viruses from bats to mesocarnivores in Arizona during 2001-2009. PLoS Pathog. 2012;8:e1002786.
   PubMed Web of Science ®Google Scholar
• Wallace RM, Gilbert A, Slate D, et al. Right place, wrong species: a 20-year review of rabies virus cross species transmission among terrestrial mammals in the United States. PLoS One. 2014;9:e107539.
   PubMed Web of Science ®Google Scholar
• Troupin C, Dacheux L, Tanguy M, et al. Large-scale phylogenomic analysis reveals the complex evolutionary history of rabies virus in multiple carnivore hosts. PLoS Pathog. 2016;12:e1006041.
   PubMed Web of Science ®Google Scholar
• Marston DA, Horton DL, Nunez J, et al. Genetic analysis of a rabies virus host shift event reveals within-host viral dynamics in a new host. Virus Evol. 2017;3:vex038.
   PubMed Web of Science ®Google Scholar
• Marston DA, Banyard AC, McElhinney LM, et al. The lyssavirus host-specificity conundrum-rabies virus-the exception not the rule. Curr Opin Virol. 2018;28:68–73.
   PubMed Web of Science ®Google Scholar
• Kotait I, Oliveira RN, Carrieri ML, et al. Non-human primates as a reservoir for rabies virus in Brazil. Zoonoses Public Health. 2019;66:47–59.
   PubMed Web of Science ®Google Scholar
• National Association of State Public Health Veterinarians; Compendium of Animal Rabies Prevention and Control Committee, Brown CM, Slavinski S, Ettestad P, Sidwa TJ, Sorhage FE. Compendium of animal rabies prevention and control, 2016. J Am Vet Med Assoc. 2016;248:505–517.
   PubMed Web of Science ®Google Scholar
• Cleaveland S, Thumbi SM, Sambo M, et al. Proof of concept of mass dog vaccination for the control and elimination of canine rabies. Rev Sci Tech. 2018;37:559–568.
   PubMed Web of Science ®Google Scholar
• Iwasaki A. Immune regulation of antibody access to neuronal tissues. Trends Mol Med. 2017;23:227–245.
   PubMed Web of Science ®Google Scholar
• Wandeler AI, Nadin-Davis SA, Tinline RR, et al. Rabies epidemiology: some ecological and evolutionary perspectives. Curr Top Microbiol Immunol. 1994;187:297–324.
   PubMedGoogle Scholar
• Dietzschold B, Morimoto K, Hooper DC, et al. Genotypic and phenotypic diversity of rabies virus variants involved in human rabies: implications for postexposure prophylaxis. J Hum Virol. 2000;3:50–57.
   PubMedGoogle Scholar
• Charlton KM, Nadin-Davis S, Casey GA, et al. The long incubation period in rabies: delayed progression of infection in muscle at the site of exposure. Acta Neuropathol. 1997;94:73–77.
   PubMed Web of Science ®Google Scholar
• Wandeler AI. Rabies vaccinology and immunology. Dev Biol (Basel). 2006;125:181–184.
   PubMedGoogle Scholar
• Li J, Faber M, Dietzschold B, et al. The role of toll-like receptors in the induction of immune responses during rabies virus infection. Adv Virus Res. 2011;79:115–126.
   PubMed Web of Science ®Google Scholar
• Dietzschold B, Li J, Faber M, et al. Concepts in the pathogenesis of rabies. Future Virol. 2008;3:481–490.
   PubMed Web of Science ®Google Scholar
• Hooper DC, Pierard I, Modelska A, et al. Rabies ribonucleocapsid as an oral immunogen and immunological enhancer. Proc Natl Acad Sci U S A. 1994;91:10908–10912.
   PubMed Web of Science ®Google Scholar
• Ertl HCJ. Human immune responses to traditional and novel rabies vaccines. Rev Sci Tech. 2018;37:649–656.
   PubMed Web of Science ®Google Scholar
• Venkataswamy MM, Madhusudana SN, Sanyal SS, et al. Cellular immune response following pre-exposure and postexposure rabies vaccination by intradermal and intramuscular routes. Clin Exp Vaccine Res. 2015;4:68–74.
   PubMed Web of Science ®Google Scholar
• Both L, Banyard AC, van Dolleweerd C, et al. Passive immunity in the prevention of rabies. Lancet Infect Dis. 2012;12:397–407.
   PubMed Web of Science ®Google Scholar
• Thraenhart O, Kreuzfelder E, Hillebrandt M, et al. Long-term humoral and cellular immunity after vaccination with cell culture rabies vaccines in man. Clin Immunol Immunopathol. 1994;71:287–292.
   PubMedGoogle Scholar
• Malerczyk C, Briggs DJ, Dreesen DW, et al. Duration of immunity: an anamnestic response 14 years after rabies vaccination with purified chick embryo cell rabies vaccine. J Travel Med. 2007;14:63–64.
   PubMed Web of Science ®Google Scholar
• Banyard AC, McElhinney LM, Johnson N, et al. History of rabies control by vaccination. Rev Sci Tech. 2018;37:305–322.
   PubMed Web of Science ®Google Scholar
• Hoenig LJ, Jackson AC, Dickinson GM. The early use of Pasteur’s rabies vaccine in the United States. Vaccine. 2018;36:4578–4581.
   PubMed Web of Science ®Google Scholar
• Udawat H, Chaudhary HR, Goyal RK, et al. Guillain-Barre syndrome following antirabies Semple vaccine–a report of six cases. J Assoc Physicians India. 2001;49:384–385.
   PubMedGoogle Scholar
• Favi M, Yung V, Roos O, et al. [Immune response of suckling mouse brain (CRL) rabies vaccine and tissue culture rabies vaccine (Verorab) in pre-exposure prophylaxis in humans]. Rev Med Chil. 2004;132:41–6.Spanish.
   PubMed Web of Science ®Google Scholar
• Moro PL, Woo EJ, Paul W, et al. Post-marketing surveillance of human rabies diploid cell vaccine (Imovax) in the vaccine adverse event reporting system (VAERS) in the United States, 1990‒2015. PLoS Negl Trop Dis. 2016;10:e0004846.
   PubMed Web of Science ®Google Scholar
• Quiambao BP, Ambas C, Diego S, et al. Intradermal post-exposure rabies vaccination with purified Vero cell rabies vaccine: comparison of a one-week, 4-site regimen versus updated Thai Red Cross regimen in a randomized non-inferiority trial in the Philippines. Vaccine. 2019;37:2268–2277.
   PubMed Web of Science ®Google Scholar
• Preiss S, Chanthavanich P, Chen LH, et al. Post-exposure prophylaxis (PEP) for rabies with purified chick embryo cell vaccine: a systematic literature review and meta-analysis. Expert Rev Vaccines. 2018;17:525–545.
   PubMed Web of Science ®Google Scholar
• Mahendra BJ, Madhusudana SN, Sampath G, et al. Immunogenicity, safety and tolerance of a purified duck embryo vaccine (PDEV, VAXIRAB) for rabies post-exposure prophylaxis: results of a multicentric study in India. Hum Vaccin. 2010;6(9). DOI:10.4161/hv.6.9.12216.
   PubMed Web of Science ®Google Scholar
• Cash RA. Testing a low-cost approach to giving eRIG for rabies PEP: ethical issues. Indian J Med Ethics. 2019;4:144–145.
   PubMedGoogle Scholar
• Matson MA, Schenker E, Stein M, et al. Safety and efficacy results of simulated post-exposure prophylaxis with human immune globulin (HRIG; KEDRAB) co-administered with active vaccine in healthy subjects: a comparative phase 2/3 trial. Hum Vaccin Immunother. 2019;24:1–8.
   Google Scholar
• Gogtay NJ, Munshi R, Ashwath Narayana DH, et al. Comparison of a novel human rabies monoclonal antibody to human rabies immunoglobulin for postexposure prophylaxis: a phase 2/3, randomized, single-blind, noninferiority, controlled study. Clin Infect Dis. 2018;66:387–395.
   PubMed Web of Science ®Google Scholar
• Rupprecht CE, Nagarajan T, Ertl H. Current status and development of vaccines and other biologics for human rabies prevention. Expert Rev Vaccines. 2016;15:731–749.
   PubMed Web of Science ®Google Scholar
• Ertl HCJ. New rabies vaccines for use in humans. Vaccines (Basel). 2019;7(2)
   PubMed Web of Science ®Google Scholar
• Rupprecht CE, Freuling C, Mani R, Palacios C, Sabeta C, Ward M.A history of rabies - the foundation for global canine rabies elimination. 2020. In: Fooks AR, Jackson AC, editors. Rabies - scientific basis of the disease and its management. 4th ed. Academic Press: San Diego. pp. 1–42.
   Google Scholar
• World Health Organization. WHO expert consultation on rabies. Third report. World Health Organ Tech Rep Ser. 2018;(1012):1–183.
   Google Scholar
• Poston R, Hill R, Allen C, et al. Achieving scientific and regulatory success in implementing non-animal approaches to human and veterinary rabies vaccine testing: A NICEATM and IABS workshop report. Biologicals. 2019;60:8–14.
   PubMed Web of Science ®Google Scholar
• Vora NM, Orciari LA, Niezgoda M, et al. Clinical management and humoral immune responses to rabies post-exposure prophylaxis among three patients who received solid organs from a donor with rabies. Transpl Infect Dis. 2015;17:389–395.
   PubMed Web of Science ®Google Scholar
• Echevarría JE, Banyard AC, McElhinney LM, et al. Current rabies vaccines do not confer protective immunity against divergent lyssaviruses circulating in Europe. Viruses. 2019;11(10). DOI:10.3390/v11100892
   Web of Science ®Google Scholar
• Dobardzic A, Izurieta H, Woo EJ, et al. Safety review of the purified chick embryo cell rabies vaccine: data from the vaccine adverse event reporting system (VAERS), 1997-2005. Vaccine. 2007;25:4244–4251.
   PubMed Web of Science ®Google Scholar
• Advisory Committee on Immunization Practices. Human rabies prevention–United States, 2008: recommendations of the advisory committee on immunization practices. MMWR. 2008;57(RR–3):1–28.
   PubMedGoogle Scholar
• World Health Organization. Causality assessment of an adverse event following immunization (AEFI): user manual for the revised WHO AEFI causality assessment classification. 2nd ed. 2018 [cited 2020 May 10]; Geneva (Switzerland). Available from: http://www.who.int/vaccine_safety/publications/gvs_aefi/en/
   Google Scholar
• Vescovo P, Rettby N, Ramaniraka N, et al. Safety, tolerability and efficacy of intradermal rabies immunization with DebioJect™. Vaccine. 2017;35:1782–1788.
   PubMed Web of Science ®Google Scholar
• Pará M. An outbreak of post-vaccinal rabies (rage de laboratoire) in Fortaleza, Brazil, in 1960. Residual fixed virus as the etiological agent. Bull World Health Organ. 1965;33:177–182.
   PubMed Web of Science ®Google Scholar
• Pannu AK, Kumar RV, Vijaykumar D, et al. Paralytic rabies: an acute flaccid myelitis after inadequate post exposure prophylaxis. Trop Doct. 2019;49:301–302.
   PubMed Web of Science ®Google Scholar
• McLaughlin DJ. Hydrophobia’s doppelgänger: toward a literary history of emotions in early american rabies narratives. Lit Med. 2019;37:113–140.
   PubMed Web of Science ®Google Scholar
• Mayet A, Nivoix P, Haus-Cheymol R, et al. Increase in reported adverse events following seasonal influenza vaccination among the French armed forces, 2008-2009: possible role of stimulated reporting and background cases of influenza-like infection. Public Health. 2012;126:70–76.
   PubMed Web of Science ®Google Scholar
• Fulbright JM, Williams SE, Pahud BA. A case of immune thrombocytopenic purpura after rabies vaccination. J Pediatr Hematol Oncol. 2015;37:e427–8.
   PubMed Web of Science ®Google Scholar
• Dato VM, Campagnolo ER, Shah DU, et al. Recurrent temporary paralysis reported after human rabies post-exposure prophylaxis. Zoonoses Public Health. 2015;62:222–227.
   PubMed Web of Science ®Google Scholar
• Kang Z, Chiang WC, Goh SH, et al. A case of serious adverse reaction following rabies vaccination. Glob Pediatr Health. 2018;5:2333794X18817143.
   PubMedGoogle Scholar
• Zhu ZG, Zheng Y, Lu S, et al. Rabies post-exposure prophylaxis for a male with severe Henoch Schönlein purpura following rabies vaccination. Hum Vaccin Immunother. 2018;14:2666–2668.
   PubMed Web of Science ®Google Scholar
• Tarantola A, Ly S, In S, et al. Rabies vaccine and rabies immunoglobulin in cambodia: use and obstacles to use. J Travel Med. 2015;22:348–352.
   PubMed Web of Science ®Google Scholar
• Hosty TS, Hunter FR. Incidence of reactions to antirabies horse serum. 433021. 1953;68:789–791.
   Google Scholar
• Tawanwongsri W, Wattanakrai P. Serum sickness after equine rabies immunoglobulin in identical male twins: two case reports. Case Rep Dermatol. 2019;11:40–47.
   PubMed Web of Science ®Google Scholar
• Neumayr A, Blum J. When horse serum meets dog bite. IDCases. 2015;3:1–2.
   PubMed Web of Science ®Google Scholar
• Kittipongwarakarn S, Hawe A, Tantipolphan R, et al. New method to produce equine antirabies immunoglobulin F(ab’)₂ fragments from crude plasma in high quality and yield. Eur J Pharm Biopharm. 2011;78:189–195.
   PubMed Web of Science ®Google Scholar
• Reveneau E, Cottin P, Rasuli A. Two decades of pharmacovigilance and clinical experience with highly purified rabies immunoglobulin F(ab’)(2) fragments. Expert Rev Vaccines. 2017;16:273–287.
   PubMed Web of Science ®Google Scholar
• Bharti OK, Thakur B, Rao R. Wound-only injection of rabies immunoglobulin (RIG) saves lives and costs less than a dollar per patient by “pooling strategy”. Vaccine. 2019;37(Suppl 1):A128–A131.
   PubMed Web of Science ®Google Scholar
• Sudarshan MK, Ashwath Narayana DH, Ravish HS. Is the skin sensitivity test required for administering equine rabies immunoglobulin? Natl Med J India. 2011;24:80–82.
   PubMed Web of Science ®Google Scholar
• Schumacher CL, Dietzschold B, Ertl HC, et al. Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies. J Clin Invest. 1989;84:971–975.
   PubMed Web of Science ®Google Scholar
• Cabasso VJ. Rabies immune globulin (human) in the prevention of rabies. Am J Hosp Pharm. 1976;33:48–51.
   PubMedGoogle Scholar
• Bakker AB, Python C, Kissling CJ, et al. First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity. Vaccine. 2008 Nov 5;26(47):5922–5927.
   PubMed Web of Science ®Google Scholar
• Müller T, Dietzschold B, Ertl H, et al. Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans. PLoS Negl Trop Dis. 2009;3:e542.
   PubMed Web of Science ®Google Scholar
• Sparrow E, Torvaldsen S, Newall AT, et al. Recent advances in the development of monoclonal antibodies for rabies postexposure prophylaxis: A review of the current status of the clinical development pipeline. Vaccine. 2019 Oct 3;37(Suppl 1):A132–A139.
   PubMed Web of Science ®Google Scholar
• Zydus to launch novel biologic for rabies, TwinrabTM. [cited 31 Jan 2020]. https://zyduscadila.com/public/pdf/pressrelease/Zydus%20to%20launch%20novel%20biologic%20for%20rabies_WHO.pdf
   Google Scholar
• Rabishield rabies human monoclonal antibody. Serum institute of India PVT. LTD. [cited 2020 Jan 31]. <https://www.seruminstitute.com/product_ind_rabishield.php>
   Google Scholar
• Narayana A, Manoharan A, Narayan MS, et al. Comparison of safety and immunogenicity of 2 WHO prequalified rabies vaccines administered by one week, 4 site intra dermal regimen (4-4-4-0-0) in animal bite cases. Hum Vaccin Immunother. 2015;11:1748–1753.
   PubMed Web of Science ®Google Scholar
• Angsuwatcharakon P, Khomvilai S, Limsuwun K, et al. Immunogenicity and safety of WHO-approved TRC-ID regimen with a chromatographically purified Vero cell rabies vaccine with or without rabies immunoglobulin in children. Expert Rev Vaccines. 2018;17:185–188.
   PubMed Web of Science ®Google Scholar
• Denis M, Knezevic I, Wilde H, et al., An overview of the immunogenicity and effectiveness of current human rabies vaccines administered by intradermal route. Vaccine. 37(Suppl 1): A99–A106. 2019.
   PubMed Web of Science ®Google Scholar
• Kerdpanich P, Chanthavanich P, De Los Reyes MR, et al. Shortening intradermal rabies post-exposure prophylaxis regimens to 1 week: results from a phase III clinical trial in children, adolescents and adults. PLoS Negl Trop Dis. 2018;12:e0006340.
   PubMed Web of Science ®Google Scholar
• Tarantola A, Tejiokem MC, Briggs DJ. Evaluating new rabies post-exposure prophylaxis (PEP) regimens or vaccines. Vaccine. 2019;37(Suppl 1):A88–A93.
   PubMed Web of Science ®Google Scholar
• Kessels J, Tarantola A, Salahuddin N, et al., Rabies post-exposure prophylaxis: A systematic review on abridged vaccination schedules and the effect of changing administration routes during a single course. Vaccine. 2019;37(Suppl 1): A107–A117. 2019.
   PubMed Web of Science ®Google Scholar
• Tarantola A, Ly S, Chan M, et al. Intradermal rabies post-exposure prophylaxis can be abridged with no measurable impact on clinical outcome in Cambodia, 2003-2014. Vaccine. 2019;37(Suppl 1):A118–A127.
   PubMed Web of Science ®Google Scholar
• Hampson K, Abela-Ridder B, Bharti O, et al. Modelling to inform prophylaxis regimens to prevent human rabies. Vaccine. 2019;37(Suppl 1):A166–A173.
   PubMed Web of Science ®Google Scholar
• Cantaert T, Borand L, Kergoat L, et al. A 1-week intradermal dose-sparing regimen for rabies post-exposure prophylaxis (RESIST-2): an observational cohort study. Lancet Infect Dis. 2019;19:1355–1362.
   PubMed Web of Science ®Google Scholar
• Bharti OK, Madhusudana SN, Gaunta PL, et al. Local infiltration of rabies immunoglobulins without systemic intramuscular administration: an alternative cost effective approach for passive immunization against rabies. Hum Vaccin Immunother. 2016;12:837–842.
   PubMed Web of Science ®Google Scholar
• Kessels JA, Recuenco S, Navarro-Vela AM, et al. Pre-exposure rabies prophylaxis: a systematic review. Bull World Health Organ. 2017;95:210–219C.
   PubMed Web of Science ®Google Scholar
• Janewongwirot P, Jantarabenjakul W, Anugulruengkitt S, et al. A randomized open-label trial of 2-dose or 3-dose pre-exposure rabies prophylaxis among Thai children. Vaccine. 2019;37:5307–5313.
   PubMed Web of Science ®Google Scholar
• Gautret P, Schlagenhauf P, Fischer PR. One-week, two-visit, double-dose, intra-dermal (2(2)ID) rabies vaccination schedule for travelers: time/dose sparing, effective but “off label”. Travel Med Infect Dis. 2020 Jan;23:101563.
   Web of Science ®Google Scholar
• Gilbert AT, Petersen BW, Recuenco S, et al. Evidence of rabies virus exposure among humans in the Peruvian Amazon. Am J Trop Med Hyg. 2012;87:206–215.
   PubMed Web of Science ®Google Scholar
• Pichon S, Guinet-Morlot F, Minutello M, et al. A serum-free, purified vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab for pre-exposure use in healthy adults: results from a randomized controlled phase-II trial. Vaccine. 2013;31:2295–2301.
   PubMed Web of Science ®Google Scholar
• Kalimuddin S, Wijaya L, Chan YFZ, et al. A phase II randomized study to determine the safety and immunogenicity of the novel PIKA rabies vaccine containing the PIKA adjuvant using an accelerated regimen. Vaccine. 2017;35:7127–7132.
   PubMed Web of Science ®Google Scholar
• Armbruster N, Jasny E, Petsch B. Advances in RNA vaccines for preventive indications: a case study of a vaccine against rabies. Vaccines (Basel). 2019;7(4). DOI:10.3390/vaccines7030071
   PubMed Web of Science ®Google Scholar
• Wang C, Dulal P, Zhou X, et al. A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis. PLoS Negl Trop Dis. 2018;12:e0006870.
   PubMed Web of Science ®Google Scholar
• McHugh KJ, Nguyen TD, Linehan AR, et al. Fabrication of fillable microparticles and other complex 3D microstructures. Science. 2017;357:1138–1142.
   PubMed Web of Science ®Google Scholar
• Appolinario CM, Jackson AC. Antiviral therapy for human rabies. Antivir Ther. 2015;20:1–10.
   PubMed Web of Science ®Google Scholar
• Du Pont V, Plemper RK, Schnell MJ. Status of antiviral therapeutics against rabies virus and related emerging lyssaviruses. Curr Opin Virol. 2019;35:1–13.
   PubMed Web of Science ®Google Scholar
• Horwitz JA, Jenni S, Harrison SC, et al. Structure of a rabies virus polymerase complex from electron cryo-microscopy. Proc Natl Acad Sci U S A. 2020;117:2099–2107.
   PubMed Web of Science ®Google Scholar
• Chung EP, Cotter JD, Prakapenka AV, et al. Targeting small molecule delivery to the brain and spinal cord via intranasal administration of rabies virus glycoprotein (RVG29)-modified PLGA nanoparticles. Pharmaceutics. 2020 Jan 24;12(2). DOI:10.3390/pharmaceutics12020093.
   Web of Science ®Google Scholar
• Tarantola A, Crabol Y, Mahendra BJ, et al. Caring for patients with rabies in developing countries - the neglected importance of palliative care. Trop Med Int Health. 2016;21:564–567.
   PubMed Web of Science ®Google Scholar
• Abela-Ridder B, Martin S, Gongal G, et al. Rabies vaccine stockpile: fixing the supply chain. Bull World Health Organ. 2016;94:635–635A.
   PubMed Web of Science ®Google Scholar
• Taylor E, Banyard AC, Bourhy H, et al. Avoiding preventable deaths: the scourge of counterfeit rabies vaccines. Vaccine. 2019;37:2285–2287.
   PubMed Web of Science ®Google Scholar
• WHO Rabies Modelling Consortium. The potential effect of improved provision of rabies post-exposure prophylaxis in Gavi-eligible countries: a modelling study. Lancet Infect Dis. 2019;19:102–111.
   PubMed Web of Science ®Google Scholar
• Rupprecht CE, Salahuddin N. Current status of human rabies prevention: remaining barriers to global biologics accessibility and disease elimination. Expert Rev Vaccines. 2019;18:629–640.
   PubMed Web of Science ®Google Scholar
• Sudarshan MK, Haradanhalli RS. Facilities and services of postexposure prophylaxis in anti-rabies clinics: A national assessment in India. Indian J Public Health. 2019;63(Supplement):S26–S30.
   PubMed Web of Science ®Google Scholar
• Neevel AMG, Hemrika T, Claassen E, et al. A research agenda to reinforce rabies control: A qualitative and quantitative prioritization. PLoS Negl Trop Dis. 2018;12:e0006387.
   PubMed Web of Science ®Google Scholar
• Quiambao BP, Ambas C, Diego S, et al. Single-visit, 4-site intradermal (ID) rabies vaccination induces robust immune responses 5 years after 1-week, 4-site ID primary post-exposure prophylaxis in the Philippines. Vaccine. 2020 May 6;38(21):3740–3746.
   PubMed Web of Science ®Google Scholar
• Wangmo K, Laven R, Cliquet F, et al. Comparison of antibody titres between intradermal and intramuscular rabies vaccination using inactivated vaccine in cattle in Bhutan. PLoS One. 2019 Jun 10;14(6):e0209946.
   PubMed Web of Science ®Google Scholar
• Rupprecht CE, Abela-Ridder B, Abila R, et al. Towards rabies elimination in the Asia-Pacific region: from theory to practice. Biologicals. 2020 Mar;64:83–95.
   PubMed Web of Science ®Google Scholar
• Gibson AD, Wallace RM, Rahman A, et al. Reviewing solutions of scale for canine rabies elimination in India. Trop Med Infect Dis. 2020 Mar 23;5(1):21.
   PubMedGoogle Scholar
• World Health Organization. 2020 April 21 [cited 2020 May 1]. Addressing human rights as key to the COVID-19 response. Geneva (Switzerland): WHO. https://www.who.int/publications-detail/addressing-human-rights-as-key-to-the-covid-19-response
   Google Scholar